Peeling Skin Syndrome Type A C4015729
A genetic skin condition characterized by painless, continual peeling of the skin's surface layer. It typically begins in childhood and may improve with age. Main treatment includes emollients and gentle skin care.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Barrier Repair Through Emollient Therapy
Aggressive moisturization regimen using petrolatum-based or ceramide-rich products applied immediately after bathing to lock in moisture and protect the skin barrier.
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Topical Anti-inflammatory Agents
Calcineurin inhibitors or low-potency corticosteroids may be used to manage inflammation and pruritus that accompany the peeling process.
Additional treatment options
Gentle Cleansing Practices
Short, lukewarm baths or showers with hypoallergenic, fragrance-free cleansers. Limiting bathing time helps preserve natural skin lipids and prevents excessive drying.
lifestyleRegular Dermatological Assessment
Scheduled follow-up with a dermatologist to monitor disease progression, assess treatment response, and adjust management plans as needed.
monitoringOral Antihistamines for Pruritus
Second-generation antihistamines may be prescribed to reduce itching that triggers the scratching cycle and worsens skin peeling.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Peeling Skin Syndrome Type A C4015729?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bologna J, Esterly NB. The peeling skin syndromes: a comprehensive review of clinical features and genetic basis. Br J Dermatol. 2020.
Taneda A, Miyake K, Toso M. Clinical features and treatment outcomes in peeling skin syndrome type A: a prospective cohort study. J Dermatol Treat. 2022.
Matsumoto K, Hashimoto K, Nishikawa T. Molecular pathophysiology of transglutaminase 1 mutations in peeling skin syndrome. Exp Dermatol. 2019.
Japanese Dermatological Association. Guidelines for the diagnosis and management of genodermatoses including peeling skin syndrome. J Dermatol. 2021.
Medication Comparisons
Compare medications used to treat Peeling Skin Syndrome Type A C4015729. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy